2017
DOI: 10.1016/j.jtho.2017.09.517
|View full text |Cite
|
Sign up to set email alerts
|

MA 08.03 Discussing Potential Recurrence after Lung Cancer Surgery: Complexity and Challenges

Abstract: delayed phase (Table). Conclusion: As a fixed oral combination of an NK 1 RA and 5HT 3 RA in a single capsule/cycle, NEPA offers a convenient and effective prophylactic antiemetic in lung cancer patients receiving cisplatin-based HEC regimens.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles